DK0650523T3 - Rekombinant CDw52-antigen - Google Patents

Rekombinant CDw52-antigen

Info

Publication number
DK0650523T3
DK0650523T3 DK93916075T DK93916075T DK0650523T3 DK 0650523 T3 DK0650523 T3 DK 0650523T3 DK 93916075 T DK93916075 T DK 93916075T DK 93916075 T DK93916075 T DK 93916075T DK 0650523 T3 DK0650523 T3 DK 0650523T3
Authority
DK
Denmark
Prior art keywords
pct
recombinant
cell lines
cdw52 antigen
date feb
Prior art date
Application number
DK93916075T
Other languages
English (en)
Inventor
Geoffrey Hale
Herman Prof Waldmann
Masahide Tone
John Tite
Christine Hale
Original Assignee
Btg Int Ltd
Geoffrey Hale
Waldmann Herman
Masahide Tone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Int Ltd, Geoffrey Hale, Waldmann Herman, Masahide Tone filed Critical Btg Int Ltd
Application granted granted Critical
Publication of DK0650523T3 publication Critical patent/DK0650523T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70592CD52

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK93916075T 1992-07-15 1993-07-14 Rekombinant CDw52-antigen DK0650523T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215071A GB9215071D0 (en) 1992-07-15 1992-07-15 Recombinant antigen
PCT/GB1993/001482 WO1994002604A1 (en) 1992-07-15 1993-07-14 RECOMBINANT CDw52 ANTIGEN

Publications (1)

Publication Number Publication Date
DK0650523T3 true DK0650523T3 (da) 2004-04-19

Family

ID=10718769

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93916075T DK0650523T3 (da) 1992-07-15 1993-07-14 Rekombinant CDw52-antigen

Country Status (10)

Country Link
US (1) US5786176A (da)
EP (1) EP0650523B1 (da)
JP (1) JP3537140B2 (da)
AT (1) ATE256737T1 (da)
DE (1) DE69333364T2 (da)
DK (1) DK0650523T3 (da)
ES (1) ES2213142T3 (da)
GB (1) GB9215071D0 (da)
PT (1) PT650523E (da)
WO (1) WO1994002604A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20065152L (fi) * 2006-03-07 2007-09-08 Schering Oy Uusi määritysmenetelmä solumembraanireseptoreihin sitoutuneiden vasta-aineiden havaitsemiseksi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185441A (en) * 1988-08-26 1993-02-09 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3
GB9108056D0 (en) * 1991-04-16 1991-06-05 Hale Geoffrey Synthetic antigen

Also Published As

Publication number Publication date
WO1994002604A1 (en) 1994-02-03
PT650523E (pt) 2004-03-31
ES2213142T3 (es) 2004-08-16
EP0650523B1 (en) 2003-12-17
DE69333364T2 (de) 2004-10-07
DE69333364D1 (de) 2004-01-29
GB9215071D0 (en) 1992-08-26
JP3537140B2 (ja) 2004-06-14
US5786176A (en) 1998-07-28
JPH07508888A (ja) 1995-10-05
ATE256737T1 (de) 2004-01-15
EP0650523A1 (en) 1995-05-03

Similar Documents

Publication Publication Date Title
DE69115267D1 (de) Antigen-/antiantigenspaltung.
MY104946A (en) Antigen antibody conjugate.
ES2181674T3 (es) Dominios de union en las proteinas notch y delta.
MY137300A (en) Chimeric proteins for use in transport of a selected substance into cells
ES8404858A1 (es) Un procedimiento para la purificacion de un anticuerpo.
ATE160575T1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
DE69021953D1 (de) Enzymimmuntest für Antigene und dafür verwendbare feste Phase.
DK0564494T3 (da) Testmetode og reagenssæt dertil
FR2706618B1 (fr) Dispositif pour le dosage d'haptènes et son utilisation.
AU525403B2 (en) Purified antigen
GR3031607T3 (en) Selective system scan for multizone radiotelephone subscriber units.
DE69216600D1 (de) Synthetisches CDw52(CAMPATH-1) Peptidantigen
DK0547200T3 (da) Rekombinante antistoffer på overfladen af E. coli
DE69333364T2 (de) REKOMBINANTES CDw52 ANTIGEN
DE3585049D1 (de) Monoklonale antikoerper.
ATE57578T1 (de) Spezifisch hemmender speichel-alpha-amylase monoklonaler antikoerper und dessen verwendung zur bestimmung von pankreas-alpha-amylase.
ATE188551T1 (de) Feststellung von antikörperproduktion
DE69434087D1 (de) ENTEROTOXINE VON SHIGELLA FLEXNERI 2a
ATE397011T1 (de) Verwendung von inhibitoren von asparaginyl- endopeptidase aus säugetieren zur modulierung des immunsystemen
DK329789A (da) Monoklonalt antistof
ATE114818T1 (de) Immuntest zum nachweis von alpha-haloacetamiden.
PH21459A (en) Process for assaying atl virus antibody and reagent therefor
ES2107545T3 (es) Anticuerpos policlonales dirigidos contra la hirudina y su utilizacion para la identificacion, la purificacion inmunologica y la determinacion cuantitativa de la hirudina.
ATE132896T1 (de) Methoden zur verwendung von an humanen klasse-ii- histokompatibilitätsantigenen mangelnden zellinien
ATE136469T1 (de) Neue verwendung eines monoklonalen antikörpers